IHC quantification revealed high levels (0.8 median score) of SSH1 in stage III tumor tissues, while tissues in stages I, II, IV and in metastatic tissue revealed weak focally positive staining intensity in groups of tumor cells (Fig. 4a, b). The gene discussed is SSH1; the disease is neoplasm.